Bruce K. Burnett

895 total citations
20 papers, 703 citations indexed

About

Bruce K. Burnett is a scholar working on Immunology, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Bruce K. Burnett has authored 20 papers receiving a total of 703 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 5 papers in Public Health, Environmental and Occupational Health and 4 papers in Epidemiology. Recurrent topics in Bruce K. Burnett's work include Virus-based gene therapy research (4 papers), Immunotherapy and Immune Responses (4 papers) and Health and Medical Research Impacts (3 papers). Bruce K. Burnett is often cited by papers focused on Virus-based gene therapy research (4 papers), Immunotherapy and Immune Responses (4 papers) and Health and Medical Research Impacts (3 papers). Bruce K. Burnett collaborates with scholars based in United States, Canada and United Kingdom. Bruce K. Burnett's co-authors include H. Kim Lyerly, Timothy M. Clay, Gayathri R. Devi, Amy Hobeika, Michael A. Morse, Takuya Osada, Jonathan Smith, Bolyn Hubby, Peter Berglund and Patrick Garnero and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Nature Immunology.

In The Last Decade

Bruce K. Burnett

20 papers receiving 654 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bruce K. Burnett United States	13	202	150	135	129	121	20	703
T T Kuo Taiwan	16	220 1.1×	86 0.6×	144 1.1×	117 0.9×	167 1.4×	35	879
R R Brown United States	11	165 0.8×	305 2.0×	188 1.4×	73 0.6×	90 0.7×	15	738
Nicholas Peake United Kingdom	14	121 0.6×	81 0.5×	162 1.2×	92 0.7×	122 1.0×	23	635
R. Saario Finland	15	594 2.9×	320 2.1×	164 1.2×	101 0.8×	117 1.0×	25	1.1k
Martin P. Alphonse United States	16	92 0.5×	206 1.4×	260 1.9×	121 0.9×	105 0.9×	39	798
William Brintnell Canada	15	292 1.4×	309 2.1×	209 1.5×	51 0.4×	399 3.3×	18	1.1k
M. Harms Switzerland	16	104 0.5×	55 0.4×	120 0.9×	65 0.5×	139 1.1×	51	759
Emel Erkek Türkiye	16	74 0.4×	68 0.5×	239 1.8×	71 0.6×	144 1.2×	45	760
Benita K. Book United States	17	50 0.2×	347 2.3×	68 0.5×	268 2.1×	184 1.5×	40	975
Tue Bjerg Bennike Denmark	11	95 0.5×	206 1.4×	271 2.0×	80 0.6×	71 0.6×	34	661

Countries citing papers authored by Bruce K. Burnett

Since Specialization

Citations

This map shows the geographic impact of Bruce K. Burnett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce K. Burnett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce K. Burnett more than expected).

Fields of papers citing papers by Bruce K. Burnett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce K. Burnett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce K. Burnett. The network helps show where Bruce K. Burnett may publish in the future.

Co-authorship network of co-authors of Bruce K. Burnett

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce K. Burnett. A scholar is included among the top collaborators of Bruce K. Burnett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce K. Burnett. Bruce K. Burnett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bluestone, Jeffrey A., Bruce K. Burnett, Mick D. Fellows, et al.. (2025). Regulatory T cell therapies to treat autoimmune diseases and transplant rejection. Nature Immunology. 26(6). 819–824. 3 indexed citations

Berglund, Jelena P., et al.. (2017). Preparation and Analysis of Peanut Flour Used in Oral Immunotherapy Clinical Trials. The Journal of Allergy and Clinical Immunology In Practice. 5(4). 1098–1104. 19 indexed citations

Bao, Xuhui, Vidyalakshmi Chandramohan, Randall Reynolds, et al.. (2016). Preclinical toxicity evaluation of a novel immunotoxin, D2C7-(scdsFv)-PE38KDEL, administered via intracerebral convection-enhanced delivery in rats. Investigational New Drugs. 34(2). 149–158. 10 indexed citations

Burnett, Bruce K., et al.. (2014). Comprehensive hands‐on training for influenza vaccine manufacturing: A WHO–BARDA–BTEC partnership for global workforce development. Biochemistry and Molecular Biology Education. 42(5). 414–419. 1 indexed citations

O’Reilly, Erin K., Denise C. Snyder, Irwin Liu, et al.. (2014). ClinicalTrials.gov Reporting: Strategies for Success at an Academic Health Center. Clinical and Translational Science. 8(1). 48–51. 14 indexed citations

Matthay, Michael A., Piero Anversa, Jahar Bhattacharya, et al.. (2013). Cell Therapy for Lung Diseases. Report from an NIH–NHLBI Workshop, November 13–14, 2012. American Journal of Respiratory and Critical Care Medicine. 188(3). 370–375. 25 indexed citations

Morse, Michael A., Arvind Chaudhry, Elizabeth S. Gabitzsch, et al.. (2013). Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients. Cancer Immunology Immunotherapy. 62(8). 1293–1301. 68 indexed citations

O’Reilly, Erin K., et al.. (2013). Warning Letters to Sponsor-Investigators at Academic Health Centres – The Regulatory “Canaries in a Coal Mine”. Clinical and investigative medicine. 36(6). E290–E296. 2 indexed citations

Adamo, Joan E., Gerhard Bauer, Bruce K. Burnett, et al.. (2012). A Roadmap for Academic Health Centers to Establish Good Laboratory Practice–Compliant Infrastructure. Academic Medicine. 87(3). 279–284. 15 indexed citations

10.

Osada, Takuya, Peter Berglund, Michael A. Morse, et al.. (2012). Co-delivery of antigen and IL-12 by Venezuelan equine encephalitis virus replicon particles enhances antigen-specific immune responses and antitumor effects. Cancer Immunology Immunotherapy. 61(11). 1941–1951. 20 indexed citations

11.

Morse, Michael A., Amy Hobeika, Arvind Chaudhry, et al.. (2012). Effect of the vaccine Ad5 [E1-, E2b-]-CEA(6D) on CEA-directed CMI responses in patients with advanced CEA-expressing malignancies in a phase I/II clinical trial.. Journal of Clinical Oncology. 30(15_suppl). 2585–2585. 1 indexed citations

12.

Kraus, Virginia B., Bruce K. Burnett, Javier Coindreau, et al.. (2011). Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis. Osteoarthritis and Cartilage. 19(5). 515–542. 249 indexed citations

13.

Morse, Michael A., Amy Hobeika, Takuya Osada, et al.. (2010). An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancer. Journal of Clinical Investigation. 120(9). 3234–3241. 96 indexed citations

14.

Berglund, Peter, et al.. (2010). Effect of a novel recombinant alphaviral vector on tolerance to self-antigen in the setting of elevated regulatory T cells.. Journal of Clinical Oncology. 28(15_suppl). 2544–2544. 2 indexed citations

15.

Burnett, Bruce K., Gregg Fromell, Karen Hartman, et al.. (2010). Support for Investigator-Initiated Clinical Research Involving Investigational Drugs or Devices: The Clinical and Translational Science Award Experience. Academic Medicine. 86(2). 217–223. 18 indexed citations

16.

Hubby, Bolyn, Todd Talarico, Maureen F. Maughan, et al.. (2007). Development and preclinical evaluation of an alphavirus replicon vaccine for influenza. Vaccine. 25(48). 8180–8189. 59 indexed citations

17.

Reap, Elizabeth A., J. Glenn Morris, Sergey A. Dryga, et al.. (2007). Development and preclinical evaluation of an alphavirus replicon particle vaccine for cytomegalovirus. Vaccine. 25(42). 7441–7449. 42 indexed citations

18.

Molinari, Michele, John R. Kachura, Elijah Dixon, et al.. (2006). Transarterial Chemoembolisation for Advanced Hepatocellular Carcinoma: Results from a North American Cancer Centre. Clinical Oncology. 18(9). 684–692. 39 indexed citations

19.

Burnett, Bruce K., Robert J. Robson, Yohtaroh Takagaki, Ramachandran Radhakrishnan, & H. G. Khorana. (1985). Synthesis of phospholipids containing photoactivatable carbene precursors in the headgroups and their crosslinking with membrane proteins. Biochimica et Biophysica Acta (BBA) - Biomembranes. 815(1). 57–67. 12 indexed citations

20.

Burnett, Bruce K. & H. G. Khorana. (1985). A rapid and efficient procedure for the purification of mitochondrial β-hydroxybutyrate dehydrogenase. Biochimica et Biophysica Acta (BBA) - Biomembranes. 815(1). 51–56. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact